Christopher K. Rode
Impact in
- Endocrinology top 0.2%
- Escherichia coli research studies
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Escherichia coli research studies 7
-
- Antibiotic Resistance in Bacteria 2
- Co-authors
- Craig A. BlochGuy PlunkettValerie BurlandDebra J. RoseFrederick R. BlattnerHeather KirkpatrickGeorge F. MayhewJeremy D. Glasner
- Journals
- Gene (3 papers)Infection and Immunity (2 papers)The Journal of Infectious Diseases (2 papers)Biotechnology Progress (2 papers)Science (1 paper)
- Partner nations
- United StatesBelgiumIreland
In The Last Decade
Christopher K. Rode
15 papers receiving 6.6k citations
Hit Papers
Peers
Comparison fields: 5 of 143
- Endocrinology 1.3k
- Molecular Medicine 519
- Genetics 2.7k
- Molecular Biology 4.7k
- Ecology 1.4k
Countries citing papers authored by Christopher K. Rode
This map shows the geographic impact of Christopher K. Rode's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher K. Rode with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher K. Rode more than expected).
Fields of papers citing papers by Christopher K. Rode
This network shows the impact of papers produced by Christopher K. Rode. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher K. Rode. The network helps show where Christopher K. Rode may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Christopher K. Rode, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 9 | |
| 2 | 2021 | 21 | |
| 3 | 2000 | 11 | |
| 4 | 1999 | 52 | |
| 5 | 1998 | 18 | |
| 6 | 1998 | 321 | |
| 7 | 1997 | 64 | |
| 8 | 1997 | 9 | |
| 9 | 1997 | 64 | |
| 10 | The Complete Genome Sequence of Escherichia coli K-12 Hit paper breakdown → | 1997 | 5909 |
| 11 | 1996 | 12 | |
| 12 | 1996 | 12 | |
| 13 | 1996 | 15 | |
| 14 | 1995 | 17 | |
| 15 | Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma. | 1994 | 250 |
About Christopher K. Rode
Christopher K. Rode is a scholar working on Endocrinology, Molecular Medicine, Ecology, Genetics and Virology, having authored 15 papers that have together received 6.8k indexed citations. Recurring topics across this work include Escherichia coli research studies (7 papers), Bacteriophages and microbial interactions (6 papers), Bacterial Genetics and Biotechnology (6 papers), RNA and protein synthesis mechanisms (4 papers), Genomics and Phylogenetic Studies (3 papers), Protein purification and stability (2 papers), Viral Infectious Diseases and Gene Expression in Insects (2 papers) and Antibiotic Resistance in Bacteria (2 papers). The work is most often cited by research in Endocrinology (1.3k citations), Molecular Medicine (519 citations), Genetics (2.7k citations), Molecular Biology (4.7k citations) and Ecology (1.4k citations). Christopher K. Rode has collaborated with scholars based in United States, Belgium and Ireland. Frequent co-authors include Craig A. Bloch, Guy Plunkett, Valerie Burland, Debra J. Rose, Frederick R. Blattner, Heather Kirkpatrick, George F. Mayhew, Jeremy D. Glasner, Nicole T. Perna and Monica Riley. Their work appears in journals such as Gene, Infection and Immunity, The Journal of Infectious Diseases, Biotechnology Progress and Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.